Discovery and development of a new drug is generally known as a very complex process which takes a lot of time and resources. So now a day's computer aided drug design approaches are used very widely to increase the efficiency of the drug discovery and development course. Various approaches of CADD are evaluated as promising techniques according to their need, in between all these structure-based drug design and ligand-based drug design approaches are known as very efficient and powerful techniques in drug discovery and development. These both methods can be applied with molecular docking to virtual screening for lead identification and optimization. In the recent times computational tools are widely used in pharmaceutical industries and research areas to improve effectiveness and efficacy of drug discovery and development pipeline. In this article we give an overview of computational approaches, which is inventive process of finding novel leads and aid in the process of drug discovery and development research.
INTRODUCTION
Computational approaches in drug design, discovery and development process gaining very rapid exploration, implementation and admiration.Introducing a new drug in a market is a very complex, risky and costly process in terms of time, money and manpower. Generally it is found that drug discovery and development process takes around 10-14 years and more than 1 billion dollars capital in total 1 . 
Major types of approaches in CADD
There are mainly two types of approaches for drug design through CADD is the following:
1. Structure based drug design / direct approach 2. Ligand based drug design / indirect approach 
CADD

Structure-based drug design
In SBDD, structure of the target protein is known and interaction or bio-affinity for all tested compounds calculate after the process of docking; to design a new drug molecule, which shows better interaction with target protein 4 . 5 .
Figure 4: Layout of SBDD
Overview of the process involved in SBDD
SBDD runs through multiple cycles before the optimized lead reached into clinical trials. The first cycle comprises isolation, purification and structure determination of the target protein by one of three key methods: like X-ray crystallography, homology modeling or NMR. Using compounds comes through virtual screening of different databases are placed into a selected region (active site) of the protein. These compounds are scored and ranked on the bases of steric, hydrophobic, electrostatic interaction of these molecules with the active site of target protein. Top ranked compounds are tested with biochemical assays.
Second cycle comprises structure determination of the protein in complex with the most optimistic lead of the first cycle, the one with minimum micro-molar inhibition in-vitro, and shows sites of the compound which can be optimized for further increment in the potency. After several additional cycles like synthesis of lead, further optimization of lead through complex structure of protein with lead compound, the optimized compounds generally show marked increment in the target specificity and binding affinity 6 . 
Ligand-Based drug design
In LBDD, 3D structure of the target protein is not known but the knowledge of ligands which binds to the desired target site is known. These ligands can be used to develop a pharmacophore model or molecule which possesses all necessary structural features for bind to a target active site. Generally ligand-based techniques are pharmacophore based approach and quantitative-structure activity relationships (QSARs). In LBDD it is assumed that compounds which having similarity in their structure also having the same biological action and interaction with the target protein 8 .
Virtual screening
Virtual screening has been worked as a most convenient tool now a day to find out the most favorable bioactive compounds with the help of information about the protein target or known active ligands. In the recent time virtual screening is known as a mind blowing alternative of high-throughput screening mainly in terms of cost effectiveness and probability of finding most appropriate novel hit through filter the large of libraries of compounds 9 . There are generally two types of virtual screening approaches like structure-based virtual screening (SBVS) and ligand-based virtual screening (LBVS), SBVS method rely on the structure of target protein active site and LBVS method is based on estimation of calculated similarity between the known active and compound come from databases. Molecular docking methodology comprises mainly three goals which are interconnected to each other like: prediction of binding pose, bio affinity and virtual screening. In the molecular docking method the basis tools are search algorithm and scoring functions for creating and analyzing conformations of the ligand 13 .
ISSN
ADVANTAGES OF CADD
 Through it we can reduce the synthetic and biological testing efforts 14 .  It gives the most promising drug candidate by eliminate the compounds with undesirable properties (poor efficacy, poor ADMET etc.) through in silico filters 15 .  It is a Cost-effective, time saving, Rapid and automatic process.  Through it we can know about the drug-receptor interaction pattern.
 It gives compounds with high hit rates through searching huge libraries of compounds in silico in comparison to traditional high throughput screening 16 .  These approaches minimize chances of failures in the final phase.
CONCLUSION AND FUTURE ASPECTS
Computer aided drug design is an efficient tool in the area of drug discovery and development, through it we can find the most promising drug candidate in a very cost-effective way. It always provides a hope for betterment in drug discovery area. In the past years through Computer aided drug design many impressive researches are achieved so it will play a very much important role in the near future. With the current achievement's, there is a promising future of computer aided drug design to aid drug discovery of many more curatives in future.
